Trial of Iressa in Prostate Cancer Patients

Summary

This study is being carried out to see if ZD1839 is effective in treating prostate cancer after being diagnosed with an early rising PSA (prostate specific antigen) following surgery.

Timeline

Start

2003-01

Primary completion

—

Completion

2011-08

Drugs

Indications